A liquid biopsy is a blood test that provides similar kinds of molecular information as solid tissue biopsies, potentially enabling cancer diagnosis and monitoring. Most existing liquid biopsy technologies use molecular changes to circulating DNA, normally circulating tumor DNA (ctDNA). However, not all cancers produce sufficient ctDNA for diagnosis, especially in early-stage cancers. We are developing quantum well nanosensors (QWNs) composed of quantum-well defects (QWDs) on single-walled carbon nanotubes (SWCNTs) to enable new research and diagnostic methods for cancers and other indications. New synthetic methods for QWD-modified SWCNTs (color center nanotubes, CCNTs, or quantum-well defect nanotubes (QWNTs)) can enable new sensitivities of QWNs, improve yield and simplify processing. We are developing arrays of QWNs for the investigation and detection of cancers and other conditions using AI-enabled methods. Via machine learning algorithms, we built prediction models of nanosensor responses that can reliably identify several cancer and non-cancer conditions, and we have expanded this approach to indications without known biomarkers, providing a general method to identify diseases. Also, by eluting and measuring the proteins captured and enriched on the QWNs (the protein corona) via mass spectrometry, QWNs enabled the discovery of new biomarkers responsible for their optical responses.